Biotime is a biotechnology company focused on research and product development in the area of regenerative medicine. BTX is centered on regenerative medicine, which refers to therapies based on human embryonic stem cell and induced pluripotent stem cell technology intended to rebuild cell and tissue function lost due to degenerative disease or injury. The company develops and sells research products in the field of stem cells, including PureStem, ESpan, HyStem and Hextend, a blood plasma volume expander for hypovolemia in surgery and other applications.  For more information, visit the company’s website at www.biotimeinc.com/